Overview

In this immersive educational program, participants will expand their understanding of managing patients with Advanced Prostate Cancer. This program utilizes the innovative AliveSim platform, offering real-life clinical case scenarios to work through in a low-stress environment with guidance from experts in the field of Oncology. Patient case scenarios created by our expert faculty will cover key oncology topics such as genetic testing, clinical treatment options and personalized care plans involving PARPi and AR directed therapy combinations. Interact with virtual patients and physicians as you practice managing Prostate cancer with expert clinical mentoring.

Target Audience

This activity is designed to educate the prostate cancer care team including oncologists, nurse practitioners, physician assistants, pharmacists, and nurse specialists.

Learning Objectives

1. Review the latest evidence for treatment of patients in high-risk BCR and metastasis-free survival
2. Outline the MOA and clinical utility of newer therapies for advanced prostate cancer
3. Examine how gene mutations and predictive biomarkers impact clinical decisions
4. Optimize management of advanced prostate cancer care and improve outcomes
5. Identify and overcome health inequities in the identification, management, and outcomes of advanced prostate cancer

Commercial Support

This activity is supported by educational grants from Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Sun Pharmaceutical Industries, Inc.